$NXTC
NextCure, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Baltimore, MD
NXTC chart
What traders are saying about $NXTC
Latest postsNextCure, Inc. news
- Capricor, NextCure reveal recent layoffs as they gear up for approval decision, merger
Fierce Biotech ·
- NextCure Cash Falls to $8.7 Million as Nine-Month Loss Reaches $31.5 Million
Minichart ·
- NextCure Inc. (NXTC) Misses Q3 EPS by 19c
StreetInsider ·
- NextCure Q3 Results: Loss narrows to $1.29 per share, beats estimates
scanx.trade ·
- NextCure 3Q 2026: EPS ($1.29) — 10-Q Summary
TradingView ·
- With $8.73M in cash, NextCure (NXTC) warns it needs funding beyond its operating runway.
Stock Titan ·
- NextCure Reports Q3 2026 Net Loss of $6.8 Million as Merger Financing Reaches $820 Million
TradingView ·
- BRIEF-NextCure Q3 Net Income USD -6.846 Million
TradingView ·
- NextCure Provides Business Update and Reports Third Quarter 2026 Financial Results
Yahoo Finance ·
- NextCure, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
www.marketscreener.com ·
- NextCure, Inc. SEC Filing (Nov 9, 2026)
Stock Titan ·
- NextCure, Inc. (NXTC) Seasonal returns chart
Yahoo Finance UK ·
NextCure, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$55.8M | -$55.7M | -$62.7M | -$74.7M |
| Diluted EPS | $-19.65 | $-23.88 | $-2.25 | $-2.69 |
| Total assets (year end) | $50.2M | $80.9M | $128.0M | $184.2M |
| Cash and equivalents (year end) | $26.0M | $27.7M | $13.1M | $26.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About NextCure, Inc.
- Ticker
- NXTC (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Baltimore, MD
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1661059
Frequently asked questions
What exchange is NextCure, Inc. listed on?
NextCure, Inc. trades on the Nasdaq under the ticker symbol NXTC.
What industry is NextCure, Inc. in?
NextCure, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is NextCure, Inc. headquartered?
NextCure, Inc.'s business address on file with the SEC is in Baltimore, MD.
When does NextCure, Inc.'s fiscal year end?
NextCure, Inc.'s fiscal year ends on December 31.
How much revenue did NextCure, Inc. report?
NextCure, Inc. reported $22.4M in revenue for calendar year 2020, according to its SEC filings.